| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 3060 | Arsenenous acid, potassium salt (9CI) | 0.00160168059169488 | 0.38775625 |
| NSC 633398 | Null | 0.00160168059169488 | 0.30792481 |
| NSC 678049 | Null | 0.0016016805916949 | 0.34203675 |
| NSC 702015 | 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- | 0.0016016805916949 | 0.32280915 |
| NSC 703174 | Null | 0.0016016805916949 | 0.55494568 |
| NSC 710266 | Null | 0.0016016805916949 | 0.4864303 |
| NSC 741412 | 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one | 0.0016016805916949 | 0.47686961 |
| NSC 658145 | 2-(2-(Dimethylamino)ethylamino)naphthazarin | 0.00166561193816139 | 0.72518862 |
| NSC 680410 | Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) | 0.00166561193816139 | 0.28550687 |
| NSC 681684 | 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol | 0.00166561193816139 | 0.62217444 |